Zachary Soler to Cohort Studies
This is a "connection" page, showing publications Zachary Soler has written about Cohort Studies.
Connection Strength
0.951
-
Impact of chronic rhinosinusitis on sleep: a controlled clinical study. Int Forum Allergy Rhinol. 2019 01; 9(1):16-22.
Score: 0.100
-
Taste impairment in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018 07; 8(7):783-789.
Score: 0.097
-
Depression in chronic rhinosinusitis: A controlled cohort study. Am J Rhinol Allergy. 2016 Mar-Apr; 30(2):128-33.
Score: 0.084
-
The Olfactory Cleft Endoscopy Scale correlates with olfactory metrics in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016 Mar; 6(3):293-8.
Score: 0.083
-
Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis. Laryngoscope. 2016 Mar; 126(3):570-4.
Score: 0.081
-
Chronic rhinosinusitis, race, and ethnicity. Am J Rhinol Allergy. 2012 Mar-Apr; 26(2):110-6.
Score: 0.064
-
Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope. 2011 Dec; 121(12):2672-8.
Score: 0.062
-
Endoscopic sphenoid nasalization for the treatment of advanced sphenoid disease. Otolaryngol Head Neck Surg. 2010 Sep; 143(3):456-8.
Score: 0.057
-
Olfactory Function After Surgical Treatment of CRS: A Comparison of CRS Patients to Healthy Controls. Am J Rhinol Allergy. 2021 May; 35(3):391-398.
Score: 0.029
-
Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019 10; 9(10):1151-1158.
Score: 0.027
-
Socioeconomic status impacts postoperative productivity loss and health utility changes in refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019 09; 9(9):1000-1009.
Score: 0.026
-
A Pilot Study of Olfactory Training in Older Hyposmic Adults. Am J Rhinol Allergy. 2019 Nov; 33(6):650-656.
Score: 0.026
-
Is greater antibiotic therapy prior to ESS associated with differences in surgical outcomes in CRS? Laryngoscope. 2019 03; 129(3):558-566.
Score: 0.025
-
Socioeconomic factors impact quality of life outcomes and olfactory measures in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019 03; 9(3):231-239.
Score: 0.025
-
Productivity changes following medical and surgical treatment of chronic rhinosinusitis by symptom domain. Int Forum Allergy Rhinol. 2018 12; 8(12):1395-1405.
Score: 0.025
-
Using postoperative SNOT-22 to help predict the probability of revision sinus surgery. Rhinology. 2016 06; 54(2):111-6.
Score: 0.021
-
Sensitivity analysis and diagnostic accuracy of the Brief Smell Identification Test in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016 Mar; 6(3):287-92.
Score: 0.021
-
Effect of Continued Medical Therapy on Productivity Costs for Refractory Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2015 Nov; 141(11):969-73.
Score: 0.020
-
Using preoperative SNOT-22 score to inform patient decision for Endoscopic sinus surgery. Laryngoscope. 2015 Jul; 125(7):1517-22.
Score: 0.019
-
SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014 Dec; 4(12):972-9.
Score: 0.019
-
Investigation of change in cardinal symptoms of chronic rhinosinusitis after surgical or ongoing medical management. Int Forum Allergy Rhinol. 2015 Jan; 5(1):36-45.
Score: 0.019
-
Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015 Jan; 125(1):25-32.
Score: 0.019